Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2025
[Comparison of the effects of transcranial magnetic stimulation and memantine on motor aphasia in ischemic stroke patients].
СтатьяРандомизированное исследованиеСравнительное исследованиеАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yusupov A U, Kilichev I A, Khudayberganov N Y
Аннотация
OBJECTIVE: To assess the effectiveness of low-frequency repetitive transcranial magnetic stimulation (rTMS) in improving chronic motor aphasia after ischemic stroke (IS) compared with memantine.
MATERIAL AND METHODS: A randomized, open-label, parallel-group study was conducted at the Urgench Rehabilitation Hospital in Urgench from February 2022 to May 2024. Patients with motor aphasia after IS were randomized into two groups.
UNLABELLED: Group 1 (n=30) received 10 sessions of a low-frequency (1 Hz) rTMS protocol. Group 2 (n=30) received memantine (initial dose 5 mg QD, increased to 20 mg QD) for eight weeks. The Western Aphasia Battery (WAB) was used for assessment before and after the intervention.
RESULTS: Intra-group comparison before and after treatment in each part of the WAB score showed a significant increase in patients' scores in both groups (p<0.001). Compared to the memantine group, the low-frequency rTMS group showed more significant improvements in word repetition and naming objects (p<0.001).
CONCLUSION: Both memantine and rTMS improved verbal function in patients with post-stroke motor aphasia. Compared to memantine, TMS treatment was associated with a more significant improvement in repetition and naming.
MATERIAL AND METHODS: A randomized, open-label, parallel-group study was conducted at the Urgench Rehabilitation Hospital in Urgench from February 2022 to May 2024. Patients with motor aphasia after IS were randomized into two groups.
UNLABELLED: Group 1 (n=30) received 10 sessions of a low-frequency (1 Hz) rTMS protocol. Group 2 (n=30) received memantine (initial dose 5 mg QD, increased to 20 mg QD) for eight weeks. The Western Aphasia Battery (WAB) was used for assessment before and after the intervention.
RESULTS: Intra-group comparison before and after treatment in each part of the WAB score showed a significant increase in patients' scores in both groups (p<0.001). Compared to the memantine group, the low-frequency rTMS group showed more significant improvements in word repetition and naming objects (p<0.001).
CONCLUSION: Both memantine and rTMS improved verbal function in patients with post-stroke motor aphasia. Compared to memantine, TMS treatment was associated with a more significant improvement in repetition and naming.